| Patent No. | Patent Title: |
| 6307030 | Androgen receptor proteins, recombinant DNA molecules coding for ... |
| 6207815 | Family of high affinity, modified antibodies for cancer treatment |
| 6207389 | Methods of controlling T lymphocyte mediated immune responses |
| 6183745 | Subunit papilloma virus vaccine and peptides for use therein |
| 6146633 | Method for treatment of antigenically modified polypeptides |
| 6143298 | Soluble truncated forms of ICAM-1 |
| 6130087 | Methods for generating cytotoxic T cells in vitro |
| 6113903 | Peptides and methods against diabetes |
| 6111071 | Recombinant fusion protein comprising PDC-E2, BCOADC-E2 and OGDC-... |
| 6096314 | Peptides and pharmaceutical compositions comprising them |
| 6086865 | Methods of treating angiogenesis-induced diseases and pharmaceuti... |
| 6086875 | Receptor specific transepithelial transport of immunogens |
| 6069001 | Isolated, truncated nucleic acid molecules which code for gage tu... |
| 6054126 | Cloning and expression of host-protective immunogens of IBDV |
| 6054292 | T-cell receptor protein |
| 6051231 | Antiviral methods and prepations |
| 6051232 | Chimeric MHC class I antigens for inducing allograft tolerance |
| 6051225 | Family of high affinity, modified antibodies for cancer treatment |
| 6048531 | Immunogenic composites capable of stimulating production of anti-... |
| 6045796 | Vaccination with peptide of MHC class II molecules for treatment ... |
| 6042837 | Methods of staphylococcal enterotoxin directed cell-mediated ... |
| 6042833 | Cellular internalization of pIgR stalk and associated ligands |
| 6039948 | Method for treatment of antigenically modified polypeptides |
| 6037135 | Methods for making HLA binding peptides and their uses |
| 6030613 | Receptor specific transepithelial transport of therapeutics |
| 6028171 | Class I MHC modulation of surface receptor activity |
| 6024966 | Gene encoding protein antigens of plasmodium falciparum and uses ... |
| 6025470 | Isolated nona- and decapeptides which bind to HLA molecules, and ... |
| 6022544 | Therapeutic suppression of specific immune responses by administr... |
| 6022966 | Pretargeting methods and compounds |
| 6020477 | DNA sequences coding for the human proteins Tx and Ty related to ... |
| 6015567 | HER2 extracellular domain |
| 6013481 | Isolated, nucleic acid molecules which code for gage tumor reject... |
| 6011146 | Altered major histocompatibility complex (MHC) determinant and me... |
| 6007815 | Anti-idiotype vaccination against diseases resulting from pathoge... |
| 6004758 | Receptor derived peptides involved in modulation of response to l... |
| 6001360 | Method and compositions for early detection and treatment of insu... |
| 5993813 | Family of high affinity, modified antibodies for cancer treatment |
| 5993827 | Binding domains from plasmodium vivax and plasmodium falciparum ... |
| 5985552 | Vaccination and methods against diseases resulting from pathogeni... |
Bizarre Patents 
PatentStorm News
